Get Real Time Here
| Open1.620 | Close- |
| Vol / Avg.5.192K / 4.178K | Mkt Cap7.709M |
| Day Range1.620 - 1.840 | 52 Wk Range1.249 - 2.720 |
Protagenic Therapeutics Stock (NASDAQ:PTIX), Quotes and News Summary
Protagenic Therapeutics Stock (NASDAQ: PTIX) stock price, news, charts, stock research, profile.
| Open1.620 | Close- |
| Vol / Avg.5.192K / 4.178K | Mkt Cap7.709M |
| Day Range1.620 - 1.840 | 52 Wk Range1.249 - 2.720 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2021-10-29 | Maxim Group | Jason McCarthy | Initiates Coverage On | Buy | Announces | - | 4.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| PTIX | Protagenic Therapeutics | -2.68% | 7.7M |
| MNPR | Monopar Therapeutics | 4.73% | 8.8M |
| BRTX | BioRestorative Therapies | -5.33% | 7.5M |
| GRTX | Galera Therapeutics | -2.1% | 8.2M |
| TRVN | Trevena | -2.9% | 9.2M |
How do I buy Protagenic Therapeutics (PTIX) stock?
You can purchase shares of Protagenic Therapeutics (NASDAQ: PTIX) through any online brokerage.
Who are Protagenic Therapeutics's (PTIX) competitors?
Other companies in Protagenic Therapeutics’s space includes: Monopar Therapeutics (NASDAQ:MNPR), BioRestorative Therapies (NASDAQ:BRTX), Galera Therapeutics (NASDAQ:GRTX), Trevena (NASDAQ:TRVN) and Theriva Biologics (AMEX:TOVX).
What is the target price for Protagenic Therapeutics (PTIX) stock?
The latest price target for Protagenic Therapeutics (NASDAQ: PTIX) was reported by Maxim Group on Friday, October 29, 2021. The analyst firm set a price target for 4.00 expecting PTIX to rise to within 12 months (a possible 124.72% upside). 0 analyst firms have reported ratings in the last year.
Current Stock Price for Protagenic Therapeutics (PTIX)?
The stock price for Protagenic Therapeutics (NASDAQ: PTIX) is $1.78 last updated Today at September 21, 2023 at 1:41 PM UTC.
Does Protagenic Therapeutics (PTIX) pay a dividend?
There is no dividend information for Protagenic Therapeutics.
When is Protagenic Therapeutics (NASDAQ:PTIX) reporting earnings?
Protagenic Therapeutics’s Q3 earnings are confirmed for Monday, November 13, 2023.
Is Protagenic Therapeutics (PTIX) going to split?
There is no upcoming split for Protagenic Therapeutics.
What sector and industry does Protagenic Therapeutics (PTIX) operate in?
Protagenic Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Protagenic Therapeutics Stock (NASDAQ:PTIX), Quotes and News Summary
Protagenic Therapeutics Stock (NASDAQ: PTIX) stock price, news, charts, stock research, profile.
| Open1.620 | Close- |
| Vol / Avg.5.192K / 4.178K | Mkt Cap7.709M |
| Day Range1.620 - 1.840 | 52 Wk Range1.249 - 2.720 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2021-10-29 | Maxim Group | Jason McCarthy | Initiates Coverage On | Buy | Announces | - | 4.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| PTIX | Protagenic Therapeutics | -2.68% | 7.7M |
| MNPR | Monopar Therapeutics | 4.73% | 8.8M |
| BRTX | BioRestorative Therapies | -5.33% | 7.5M |
| GRTX | Galera Therapeutics | -2.1% | 8.2M |
| TRVN | Trevena | -2.9% | 9.2M |
How do I buy Protagenic Therapeutics (PTIX) stock?
You can purchase shares of Protagenic Therapeutics (NASDAQ: PTIX) through any online brokerage.
Who are Protagenic Therapeutics's (PTIX) competitors?
Other companies in Protagenic Therapeutics’s space includes: Monopar Therapeutics (NASDAQ:MNPR), BioRestorative Therapies (NASDAQ:BRTX), Galera Therapeutics (NASDAQ:GRTX), Trevena (NASDAQ:TRVN) and Theriva Biologics (AMEX:TOVX).
What is the target price for Protagenic Therapeutics (PTIX) stock?
The latest price target for Protagenic Therapeutics (NASDAQ: PTIX) was reported by Maxim Group on Friday, October 29, 2021. The analyst firm set a price target for 4.00 expecting PTIX to rise to within 12 months (a possible 124.72% upside). 0 analyst firms have reported ratings in the last year.
Current Stock Price for Protagenic Therapeutics (PTIX)?
The stock price for Protagenic Therapeutics (NASDAQ: PTIX) is $1.78 last updated Today at September 21, 2023 at 1:41 PM UTC.
Does Protagenic Therapeutics (PTIX) pay a dividend?
There is no dividend information for Protagenic Therapeutics.
When is Protagenic Therapeutics (NASDAQ:PTIX) reporting earnings?
Protagenic Therapeutics’s Q3 earnings are confirmed for Monday, November 13, 2023.
Is Protagenic Therapeutics (PTIX) going to split?
There is no upcoming split for Protagenic Therapeutics.
What sector and industry does Protagenic Therapeutics (PTIX) operate in?
Protagenic Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Protagenic Therapeutics Stock (NASDAQ:PTIX), Quotes and News Summary
Protagenic Therapeutics Stock (NASDAQ: PTIX) stock price, news, charts, stock research, profile.
| Open1.620 | Close- |
| Vol / Avg.5.192K / 4.178K | Mkt Cap7.709M |
| Day Range1.620 - 1.840 | 52 Wk Range1.249 - 2.720 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2021-10-29 | Maxim Group | Jason McCarthy | Initiates Coverage On | Buy | Announces | - | 4.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| PTIX | Protagenic Therapeutics | -2.68% | 7.7M |
| MNPR | Monopar Therapeutics | 4.73% | 8.8M |
| BRTX | BioRestorative Therapies | -5.33% | 7.5M |
| GRTX | Galera Therapeutics | -2.1% | 8.2M |
| TRVN | Trevena | -2.9% | 9.2M |
How do I buy Protagenic Therapeutics (PTIX) stock?
You can purchase shares of Protagenic Therapeutics (NASDAQ: PTIX) through any online brokerage.
Who are Protagenic Therapeutics's (PTIX) competitors?
Other companies in Protagenic Therapeutics’s space includes: Monopar Therapeutics (NASDAQ:MNPR), BioRestorative Therapies (NASDAQ:BRTX), Galera Therapeutics (NASDAQ:GRTX), Trevena (NASDAQ:TRVN) and Theriva Biologics (AMEX:TOVX).
What is the target price for Protagenic Therapeutics (PTIX) stock?
The latest price target for Protagenic Therapeutics (NASDAQ: PTIX) was reported by Maxim Group on Friday, October 29, 2021. The analyst firm set a price target for 4.00 expecting PTIX to rise to within 12 months (a possible 124.72% upside). 0 analyst firms have reported ratings in the last year.
Current Stock Price for Protagenic Therapeutics (PTIX)?
The stock price for Protagenic Therapeutics (NASDAQ: PTIX) is $1.78 last updated Today at September 21, 2023 at 1:41 PM UTC.
Does Protagenic Therapeutics (PTIX) pay a dividend?
There is no dividend information for Protagenic Therapeutics.
When is Protagenic Therapeutics (NASDAQ:PTIX) reporting earnings?
Protagenic Therapeutics’s Q3 earnings are confirmed for Monday, November 13, 2023.
Is Protagenic Therapeutics (PTIX) going to split?
There is no upcoming split for Protagenic Therapeutics.
What sector and industry does Protagenic Therapeutics (PTIX) operate in?
Protagenic Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Protagenic Therapeutics Stock (NASDAQ:PTIX), Quotes and News Summary
Protagenic Therapeutics Stock (NASDAQ: PTIX) stock price, news, charts, stock research, profile.
| Open1.620 | Close- |
| Vol / Avg.5.192K / 4.178K | Mkt Cap7.709M |
| Day Range1.620 - 1.840 | 52 Wk Range1.249 - 2.720 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2021-10-29 | Maxim Group | Jason McCarthy | Initiates Coverage On | Buy | Announces | - | 4.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| PTIX | Protagenic Therapeutics | -2.68% | 7.7M |
| MNPR | Monopar Therapeutics | 4.73% | 8.8M |
| BRTX | BioRestorative Therapies | -5.33% | 7.5M |
| GRTX | Galera Therapeutics | -2.1% | 8.2M |
| TRVN | Trevena | -2.9% | 9.2M |
How do I buy Protagenic Therapeutics (PTIX) stock?
You can purchase shares of Protagenic Therapeutics (NASDAQ: PTIX) through any online brokerage.
Who are Protagenic Therapeutics's (PTIX) competitors?
Other companies in Protagenic Therapeutics’s space includes: Monopar Therapeutics (NASDAQ:MNPR), BioRestorative Therapies (NASDAQ:BRTX), Galera Therapeutics (NASDAQ:GRTX), Trevena (NASDAQ:TRVN) and Theriva Biologics (AMEX:TOVX).
What is the target price for Protagenic Therapeutics (PTIX) stock?
The latest price target for Protagenic Therapeutics (NASDAQ: PTIX) was reported by Maxim Group on Friday, October 29, 2021. The analyst firm set a price target for 4.00 expecting PTIX to rise to within 12 months (a possible 124.72% upside). 0 analyst firms have reported ratings in the last year.
Current Stock Price for Protagenic Therapeutics (PTIX)?
The stock price for Protagenic Therapeutics (NASDAQ: PTIX) is $1.78 last updated Today at September 21, 2023 at 1:41 PM UTC.
Does Protagenic Therapeutics (PTIX) pay a dividend?
There is no dividend information for Protagenic Therapeutics.
When is Protagenic Therapeutics (NASDAQ:PTIX) reporting earnings?
Protagenic Therapeutics’s Q3 earnings are confirmed for Monday, November 13, 2023.
Is Protagenic Therapeutics (PTIX) going to split?
There is no upcoming split for Protagenic Therapeutics.
What sector and industry does Protagenic Therapeutics (PTIX) operate in?
Protagenic Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Protagenic Therapeutics Stock (NASDAQ:PTIX), Quotes and News Summary
Protagenic Therapeutics Stock (NASDAQ: PTIX) stock price, news, charts, stock research, profile.
| Open1.620 | Close- |
| Vol / Avg.5.192K / 4.178K | Mkt Cap7.709M |
| Day Range1.620 - 1.840 | 52 Wk Range1.249 - 2.720 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2021-10-29 | Maxim Group | Jason McCarthy | Initiates Coverage On | Buy | Announces | - | 4.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| PTIX | Protagenic Therapeutics | -2.68% | 7.7M |
| MNPR | Monopar Therapeutics | 4.73% | 8.8M |
| BRTX | BioRestorative Therapies | -5.33% | 7.5M |
| GRTX | Galera Therapeutics | -2.1% | 8.2M |
| TRVN | Trevena | -2.9% | 9.2M |
How do I buy Protagenic Therapeutics (PTIX) stock?
You can purchase shares of Protagenic Therapeutics (NASDAQ: PTIX) through any online brokerage.
Who are Protagenic Therapeutics's (PTIX) competitors?
Other companies in Protagenic Therapeutics’s space includes: Monopar Therapeutics (NASDAQ:MNPR), BioRestorative Therapies (NASDAQ:BRTX), Galera Therapeutics (NASDAQ:GRTX), Trevena (NASDAQ:TRVN) and Theriva Biologics (AMEX:TOVX).
What is the target price for Protagenic Therapeutics (PTIX) stock?
The latest price target for Protagenic Therapeutics (NASDAQ: PTIX) was reported by Maxim Group on Friday, October 29, 2021. The analyst firm set a price target for 4.00 expecting PTIX to rise to within 12 months (a possible 124.72% upside). 0 analyst firms have reported ratings in the last year.
Current Stock Price for Protagenic Therapeutics (PTIX)?
The stock price for Protagenic Therapeutics (NASDAQ: PTIX) is $1.78 last updated Today at September 21, 2023 at 1:41 PM UTC.
Does Protagenic Therapeutics (PTIX) pay a dividend?
There is no dividend information for Protagenic Therapeutics.
When is Protagenic Therapeutics (NASDAQ:PTIX) reporting earnings?
Protagenic Therapeutics’s Q3 earnings are confirmed for Monday, November 13, 2023.
Is Protagenic Therapeutics (PTIX) going to split?
There is no upcoming split for Protagenic Therapeutics.
What sector and industry does Protagenic Therapeutics (PTIX) operate in?
Protagenic Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Protagenic Therapeutics Stock (NASDAQ:PTIX), Quotes and News Summary
Protagenic Therapeutics Stock (NASDAQ: PTIX) stock price, news, charts, stock research, profile.
| Open1.620 | Close- |
| Vol / Avg.5.192K / 4.178K | Mkt Cap7.709M |
| Day Range1.620 - 1.840 | 52 Wk Range1.249 - 2.720 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2021-10-29 | Maxim Group | Jason McCarthy | Initiates Coverage On | Buy | Announces | - | 4.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| PTIX | Protagenic Therapeutics | -2.68% | 7.7M |
| MNPR | Monopar Therapeutics | 4.73% | 8.8M |
| BRTX | BioRestorative Therapies | -5.33% | 7.5M |
| GRTX | Galera Therapeutics | -2.1% | 8.2M |
| TRVN | Trevena | -2.9% | 9.2M |
How do I buy Protagenic Therapeutics (PTIX) stock?
You can purchase shares of Protagenic Therapeutics (NASDAQ: PTIX) through any online brokerage.
Who are Protagenic Therapeutics's (PTIX) competitors?
Other companies in Protagenic Therapeutics’s space includes: Monopar Therapeutics (NASDAQ:MNPR), BioRestorative Therapies (NASDAQ:BRTX), Galera Therapeutics (NASDAQ:GRTX), Trevena (NASDAQ:TRVN) and Theriva Biologics (AMEX:TOVX).
What is the target price for Protagenic Therapeutics (PTIX) stock?
The latest price target for Protagenic Therapeutics (NASDAQ: PTIX) was reported by Maxim Group on Friday, October 29, 2021. The analyst firm set a price target for 4.00 expecting PTIX to rise to within 12 months (a possible 124.72% upside). 0 analyst firms have reported ratings in the last year.
Current Stock Price for Protagenic Therapeutics (PTIX)?
The stock price for Protagenic Therapeutics (NASDAQ: PTIX) is $1.78 last updated Today at September 21, 2023 at 1:41 PM UTC.
Does Protagenic Therapeutics (PTIX) pay a dividend?
There is no dividend information for Protagenic Therapeutics.
When is Protagenic Therapeutics (NASDAQ:PTIX) reporting earnings?
Protagenic Therapeutics’s Q3 earnings are confirmed for Monday, November 13, 2023.
Is Protagenic Therapeutics (PTIX) going to split?
There is no upcoming split for Protagenic Therapeutics.
What sector and industry does Protagenic Therapeutics (PTIX) operate in?
Protagenic Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Protagenic Therapeutics Stock (NASDAQ:PTIX), Quotes and News Summary
Protagenic Therapeutics Stock (NASDAQ: PTIX) stock price, news, charts, stock research, profile.
| Open1.620 | Close- |
| Vol / Avg.5.192K / 4.178K | Mkt Cap7.709M |
| Day Range1.620 - 1.840 | 52 Wk Range1.249 - 2.720 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2021-10-29 | Maxim Group | Jason McCarthy | Initiates Coverage On | Buy | Announces | - | 4.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| PTIX | Protagenic Therapeutics | -2.68% | 7.7M |
| MNPR | Monopar Therapeutics | 4.73% | 8.8M |
| BRTX | BioRestorative Therapies | -5.33% | 7.5M |
| GRTX | Galera Therapeutics | -2.1% | 8.2M |
| TRVN | Trevena | -2.9% | 9.2M |
How do I buy Protagenic Therapeutics (PTIX) stock?
You can purchase shares of Protagenic Therapeutics (NASDAQ: PTIX) through any online brokerage.
Who are Protagenic Therapeutics's (PTIX) competitors?
Other companies in Protagenic Therapeutics’s space includes: Monopar Therapeutics (NASDAQ:MNPR), BioRestorative Therapies (NASDAQ:BRTX), Galera Therapeutics (NASDAQ:GRTX), Trevena (NASDAQ:TRVN) and Theriva Biologics (AMEX:TOVX).
What is the target price for Protagenic Therapeutics (PTIX) stock?
The latest price target for Protagenic Therapeutics (NASDAQ: PTIX) was reported by Maxim Group on Friday, October 29, 2021. The analyst firm set a price target for 4.00 expecting PTIX to rise to within 12 months (a possible 124.72% upside). 0 analyst firms have reported ratings in the last year.
Current Stock Price for Protagenic Therapeutics (PTIX)?
The stock price for Protagenic Therapeutics (NASDAQ: PTIX) is $1.78 last updated Today at September 21, 2023 at 1:41 PM UTC.
Does Protagenic Therapeutics (PTIX) pay a dividend?
There is no dividend information for Protagenic Therapeutics.
When is Protagenic Therapeutics (NASDAQ:PTIX) reporting earnings?
Protagenic Therapeutics’s Q3 earnings are confirmed for Monday, November 13, 2023.
Is Protagenic Therapeutics (PTIX) going to split?
There is no upcoming split for Protagenic Therapeutics.
What sector and industry does Protagenic Therapeutics (PTIX) operate in?
Protagenic Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Protagenic Therapeutics Stock (NASDAQ:PTIX), Quotes and News Summary
Protagenic Therapeutics Stock (NASDAQ: PTIX) stock price, news, charts, stock research, profile.
| Open1.620 | Close- |
| Vol / Avg.5.192K / 4.178K | Mkt Cap7.709M |
| Day Range1.620 - 1.840 | 52 Wk Range1.249 - 2.720 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2021-10-29 | Maxim Group | Jason McCarthy | Initiates Coverage On | Buy | Announces | - | 4.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| PTIX | Protagenic Therapeutics | -2.68% | 7.7M |
| MNPR | Monopar Therapeutics | 4.73% | 8.8M |
| BRTX | BioRestorative Therapies | -5.33% | 7.5M |
| GRTX | Galera Therapeutics | -2.1% | 8.2M |
| TRVN | Trevena | -2.9% | 9.2M |
How do I buy Protagenic Therapeutics (PTIX) stock?
You can purchase shares of Protagenic Therapeutics (NASDAQ: PTIX) through any online brokerage.
Who are Protagenic Therapeutics's (PTIX) competitors?
Other companies in Protagenic Therapeutics’s space includes: Monopar Therapeutics (NASDAQ:MNPR), BioRestorative Therapies (NASDAQ:BRTX), Galera Therapeutics (NASDAQ:GRTX), Trevena (NASDAQ:TRVN) and Theriva Biologics (AMEX:TOVX).
What is the target price for Protagenic Therapeutics (PTIX) stock?
The latest price target for Protagenic Therapeutics (NASDAQ: PTIX) was reported by Maxim Group on Friday, October 29, 2021. The analyst firm set a price target for 4.00 expecting PTIX to rise to within 12 months (a possible 124.72% upside). 0 analyst firms have reported ratings in the last year.
Current Stock Price for Protagenic Therapeutics (PTIX)?
The stock price for Protagenic Therapeutics (NASDAQ: PTIX) is $1.78 last updated Today at September 21, 2023 at 1:41 PM UTC.
Does Protagenic Therapeutics (PTIX) pay a dividend?
There is no dividend information for Protagenic Therapeutics.
When is Protagenic Therapeutics (NASDAQ:PTIX) reporting earnings?
Protagenic Therapeutics’s Q3 earnings are confirmed for Monday, November 13, 2023.
Is Protagenic Therapeutics (PTIX) going to split?
There is no upcoming split for Protagenic Therapeutics.
What sector and industry does Protagenic Therapeutics (PTIX) operate in?
Protagenic Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Protagenic Therapeutics Stock (NASDAQ:PTIX), Quotes and News Summary
Protagenic Therapeutics Stock (NASDAQ: PTIX) stock price, news, charts, stock research, profile.
| Open1.620 | Close- |
| Vol / Avg.5.192K / 4.178K | Mkt Cap7.709M |
| Day Range1.620 - 1.840 | 52 Wk Range1.249 - 2.720 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2021-10-29 | Maxim Group | Jason McCarthy | Initiates Coverage On | Buy | Announces | - | 4.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| PTIX | Protagenic Therapeutics | -2.68% | 7.7M |
| MNPR | Monopar Therapeutics | 4.73% | 8.8M |
| BRTX | BioRestorative Therapies | -5.33% | 7.5M |
| GRTX | Galera Therapeutics | -2.1% | 8.2M |
| TRVN | Trevena | -2.9% | 9.2M |
How do I buy Protagenic Therapeutics (PTIX) stock?
You can purchase shares of Protagenic Therapeutics (NASDAQ: PTIX) through any online brokerage.
Who are Protagenic Therapeutics's (PTIX) competitors?
Other companies in Protagenic Therapeutics’s space includes: Monopar Therapeutics (NASDAQ:MNPR), BioRestorative Therapies (NASDAQ:BRTX), Galera Therapeutics (NASDAQ:GRTX), Trevena (NASDAQ:TRVN) and Theriva Biologics (AMEX:TOVX).
What is the target price for Protagenic Therapeutics (PTIX) stock?
The latest price target for Protagenic Therapeutics (NASDAQ: PTIX) was reported by Maxim Group on Friday, October 29, 2021. The analyst firm set a price target for 4.00 expecting PTIX to rise to within 12 months (a possible 124.72% upside). 0 analyst firms have reported ratings in the last year.
Current Stock Price for Protagenic Therapeutics (PTIX)?
The stock price for Protagenic Therapeutics (NASDAQ: PTIX) is $1.78 last updated Today at September 21, 2023 at 1:41 PM UTC.
Does Protagenic Therapeutics (PTIX) pay a dividend?
There is no dividend information for Protagenic Therapeutics.
When is Protagenic Therapeutics (NASDAQ:PTIX) reporting earnings?
Protagenic Therapeutics’s Q3 earnings are confirmed for Monday, November 13, 2023.
Is Protagenic Therapeutics (PTIX) going to split?
There is no upcoming split for Protagenic Therapeutics.
What sector and industry does Protagenic Therapeutics (PTIX) operate in?
Protagenic Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.